Related Experiment Video
Updated: Feb 2, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Right ventricular function in infants with bronchopulmonary dysplasia and pulmonary hypertension: a pilot study
Arabella J Blanca1, Liesbeth Duijts2,3, Esther van Mastrigt2
11 Division of Pediatric Cardiology, Department of Pediatrics, Erasmus Medical Centre, Sophia Children's Hospital, Rotterdam, The Netherlands.
Insights
Twelve percent of premature infants with severe bronchopulmonary dysplasia (BPD) showed signs of pulmonary hypertension (PH) at six months. This PH was linked to reduced right ventricular systolic function in these children.
Area of Science:
- Pediatric Cardiology
- Neonatology
- Pulmonary Medicine
Background:
- Premature birth and bronchopulmonary dysplasia (BPD) are known risk factors for developing pulmonary hypertension (PH) and cardiac changes.
- It remains unclear if this association between BPD and PH persists beyond early infancy.
Purpose of the Study:
- To prospectively assess the prevalence of PH in children with severe BPD at six months corrected age.
- To investigate the impact of BPD and PH on myocardial structure and function at six months corrected age.
Main Methods:
- Prospective study including preterm infants (gestational age ≤ 32 weeks) with severe BPD.
- Echocardiography used to diagnose PH and measure left ventricle (LV) and right ventricle (RV) strain via speckle tracking.
- Evaluated RV fractional area change, RV size, and LV/RV longitudinal and circumferential strain.
Main Results:
- Eight out of 69 infants (12%) exhibited signs of PH at six months corrected age.
- Infants with severe BPD and PH showed significantly lower RV fractional area change (35% ± 9% vs. 43% ± 9%) and RV longitudinal systolic strain (-17.6% vs. -20.9%).
- RV size and LV strain were similar between infants with and without PH.
Conclusions:
- Pulmonary hypertension is present in 12% of infants with severe BPD at six months corrected age.
- The presence of PH in this cohort is associated with impaired right ventricular systolic function.
- Further research is needed to understand the long-term cardiac implications of BPD-associated PH.
Abstract:
Premature birth and bronchopulmonary dysplasia (BPD) are risk factors for the development of echocardiographic signs of pulmonary hypertension (PH) and are associated with changes in cardiac structure and function. It is unclear whether this association persists beyond early infancy. The aims of this study are to prospectively investigate the prevalence of PH in children with severe BPD and to investigate the effect of BPD and PH on myocardial structure and function at six months corrected age. Preterm infants (gestational age ≤ 32 weeks) with severe BPD were included. Echocardiography was used to define PH and to measure speckle tracking derived longitudinal and circumferential strain of the left ventricle (LV) and right ventricle (RV). Sixty-nine infants with a median (interquartile range [IQR]) gestational age of 25.6 (24.9-26.4) weeks and a median birthweight of 770 (645-945) gram were included. Eight (12%) infants had signs of PH at six months corrected age. RV fractional area change was lower in infants with severe BPD and PH at six months compared to infants without PH (35% ± 9% vs. 43% ± 9%, P = 0.03). RV mean longitudinal systolic strain was lower in infants with severe BPD and PH compared to infants without PH (17.6% [-19.5%/-16.1%] vs. -20.9% [-25.9%/-17.9%], P = 0.04). RV size and LV longitudinal and circumferential strain in children with BPD with or without PH were similar. Signs of PH were found in 12% of infants with severe BPD at six months corrected age and the presence of PH is associated with reduced RV systolic function.
More Related Videos
09:22Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
07:02A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep
Published on: July 15, 2021
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...